Dyslipidemia, Hypertension
Conditions
Keywords
hypertension, compliance
Brief summary
The RATCHET study assesses if patient knowledge of estimated cardiovascular risk at current and recommended target blood pressure levels improves compliance in the management of hypertension.
Interventions
BEHAVIORALKnowledge of Cardiovascular Risk Assessment
Knowledge of Cardiovascular Risk Assessment and risk reduction at target BP, reviewed every 3-6 months.
Sponsors
University of Western Ontario, Canada
The Physicians' Services Incorporated Foundation
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
30 Years to 84 Years
Healthy volunteers
No
Inclusion criteria
* Essential hypertension (new diagnosis or established diagnosis) meeting criteria for pharmacologic therapy as defined by current guidelines
Exclusion criteria
* Lack of written informed consent * Previous myocardial infarction * Previous stroke * Congestive heart failure * Stage 3 or greater chronic kidney disease * Pregnancy * Usage of medication bubble/blister package
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Medication Compliance | 1 year |
Secondary
| Measure | Time frame |
|---|---|
| Patient perception of cardiovascular risk | 1 year |
| Pilot Feasibility Study | 1 year |
| Blood Pressure | 1 year |
| Cholesterol Level | 1 year |
| Framingham Risk Score (stroke and coronary artery disease) | 1 year |
Countries
Canada
Outcome results
None listed